10x Genomics Stock Price Prediction
| TXG Stock | USD 15.08 0.24 1.62% |
Oversold Vs Overbought
48
Oversold | Overbought |
EPS Estimate Next Quarter (0.23) | EPS Estimate Current Year (0.61) | EPS Estimate Next Year (0.60) | Wall Street Target Price 20.1429 | EPS Estimate Current Quarter (0.34) |
Using 10X Genomics hype-based prediction, you can estimate the value of 10X Genomics from the perspective of 10X Genomics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards 10X Genomics using 10X Genomics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards 10X using crowd psychology based on the activity and movement of 10X Genomics' stock price.
10X Genomics Short Interest
A significant increase or decrease in 10X Genomics' short interest from the previous month could be a good indicator of investor sentiment towards 10X. Short interest can provide insight into the potential direction of 10X Genomics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 19.7647 | Short Percent 0.0823 | Short Ratio 4.26 | Shares Short Prior Month 6.6 M | 50 Day MA 14.9523 |
10X Genomics Hype to Price Pattern
Investor biases related to 10X Genomics' public news can be used to forecast risks associated with an investment in 10X. The trend in average sentiment can be used to explain how an investor holding 10X can time the market purely based on public headlines and social activities around 10X Genomics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of 10X Genomics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about 10X Genomics.
10X Genomics Implied Volatility | 1.42 |
10X Genomics' implied volatility exposes the market's sentiment of 10X Genomics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if 10X Genomics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that 10X Genomics stock will not fluctuate a lot when 10X Genomics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in 10X Genomics to buy its stock at a price that has no basis in reality. In that case, they are not buying 10X because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
10X Genomics after-hype prediction price | USD 14.81 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current 10X contract
Based on the Rule 16, the options market is currently suggesting that 10X Genomics will have an average daily up or down price movement of about 0.0888% per day over the life of the 2025-03-21 option contract. With 10X Genomics trading at USD 15.08, that is roughly USD 0.0134 . If you think that the market is fully incorporating 10X Genomics' daily price movement you should consider acquiring 10X Genomics options at the current volatility level of 1.42%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
10X |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 10X Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
10X Genomics After-Hype Price Prediction Density Analysis
As far as predicting the price of 10X Genomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in 10X Genomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of 10X Genomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
10X Genomics Estimiated After-Hype Price Volatility
In the context of predicting 10X Genomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on 10X Genomics' historical news coverage. 10X Genomics' after-hype downside and upside margins for the prediction period are 11.01 and 18.61, respectively. We have considered 10X Genomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
10X Genomics is not too volatile at this time. Analysis and calculation of next after-hype price of 10X Genomics is based on 3 months time horizon.
10X Genomics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as 10X Genomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 10X Genomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with 10X Genomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 3.77 | 0.02 | 0.01 | 9 Events / Month | 4 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
15.08 | 14.81 | 0.20 |
|
10X Genomics Hype Timeline
On the 30th of January 10X Genomics is traded for 15.08. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.01. 10X is anticipated to decline in value after the next headline, with the price expected to drop to 14.81. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -0.2%, whereas the daily expected return is at this time at -0.06%. The volatility of related hype on 10X Genomics is about 1653.51%, with the expected price after the next announcement by competition of 15.09. About 97.0% of the company shares are owned by institutional investors. The book value of 10X Genomics was at this time reported as 5.97. The company has Price/Earnings To Growth (PEG) ratio of 0.13. 10X Genomics recorded a loss per share of 1.52. The entity had not issued any dividends in recent years. The firm had 1:2 split on the 17th of July 2006. Considering the 90-day investment horizon the next anticipated press release will be in about 9 days. Check out 10X Genomics Basic Forecasting Models to cross-verify your projections.10X Genomics Related Hype Analysis
Having access to credible news sources related to 10X Genomics' direct competition is more important than ever and may enhance your ability to predict 10X Genomics' future price movements. Getting to know how 10X Genomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how 10X Genomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TWST | Twist Bioscience Corp | 1.99 | 13 per month | 3.51 | 0.07 | 6.39 | (6.12) | 20.14 | |
| FATE | Fate Therapeutics | 0.00 | 9 per month | 0.00 | (0.16) | 11.34 | (11.47) | 34.46 | |
| BEAM | Beam Therapeutics | (2.20) | 7 per month | 3.82 | 0.06 | 8.04 | (7.94) | 20.93 | |
| VCYT | Veracyte | (0.63) | 10 per month | 2.44 | 0.15 | 4.66 | (4.02) | 13.06 | |
| GH | Guardant Health | 1.98 | 10 per month | 1.90 | 0.29 | 8.24 | (3.80) | 25.96 |
10X Genomics Additional Predictive Modules
Most predictive techniques to examine 10X price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for 10X using various technical indicators. When you analyze 10X charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About 10X Genomics Predictive Indicators
The successful prediction of 10X Genomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as 10X Genomics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of 10X Genomics based on analysis of 10X Genomics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to 10X Genomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to 10X Genomics's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 5.57 | 13.31 | 11.98 | 12.57 | Days Of Inventory On Hand | 247.49 | 128.47 | 115.62 | 140.12 |
Story Coverage note for 10X Genomics
The number of cover stories for 10X Genomics depends on current market conditions and 10X Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that 10X Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about 10X Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
10X Genomics Short Properties
10X Genomics' future price predictability will typically decrease when 10X Genomics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of 10X Genomics often depends not only on the future outlook of the potential 10X Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 10X Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 117.2 M | |
| Cash And Short Term Investments | 388.7 M |
Complementary Tools for 10X Stock analysis
When running 10X Genomics' price analysis, check to measure 10X Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X Genomics is operating at the current time. Most of 10X Genomics' value examination focuses on studying past and present price action to predict the probability of 10X Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X Genomics' price. Additionally, you may evaluate how the addition of 10X Genomics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |